A higher adherence to perindopril-based anti-hypertensive therapy is associated with a reduced risk of cardiovascular outcomes and all-cause mortality in real clinical practice in Italy
1 September 2024 (15:00 - 15:50)
Organised by: 
About the speaker
University of Pisa, Pisa (Italy)
7 More presentations in this session
Professor P. Rossing (Herlev, DK)
Associate Professor A. Vintila (Bucharest, RO)
Doctor C. Kennedy (Dublin, IE)
Doctor S. Masi (Pisa, IT)
Associate Professor J. Wolf (Gdansk, PL)
Doctor A. Yadav (New Delhi, IN)
Access the full session
The Event
ESC Congress 2024
1 September 2024
15:00 CET
